TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 72 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,965,132,000 | +124433.1% | 20,699 | +34.4% | 0.23% | +19.2% |
| Q4 2015 | $2,381,000 | +43.3% | 15,404 | +32.4% | 0.19% | +30.4% |
| Q3 2015 | $1,662,000 | +23.7% | 11,631 | +24.4% | 0.15% | +20.3% |
| Q2 2015 | $1,344,000 | +32.2% | 9,351 | +29.8% | 0.12% | +33.7% |
| Q1 2015 | $1,017,000 | +19.2% | 7,202 | +25.2% | 0.09% | +17.9% |
| Q4 2014 | $853,000 | +4.3% | 5,754 | +8.2% | 0.08% | +9.9% |
| Q3 2014 | $818,000 | +21.7% | 5,316 | +10.8% | 0.07% | +26.8% |
| Q2 2014 | $672,000 | +44.5% | 4,797 | +14.5% | 0.06% | +40.0% |
| Q1 2014 | $465,000 | – | 4,190 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |